AcelRx Pharmaceuticals, Inc. (ACRX) Financials

NASDAQ Currency in USD Disclaimer

$0.40

Last update: 02:03 PM EST
Day's range
$0.4
Day's range
$0.44
$60M$60M$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60MEarning201820182019201920202020202120212022202220232023202420243000%3000%2000%2000%1000%1000%0%0%-1000%-1000%-2000%-2000%-3000%-3000%Profit Margin
Profit Margin
Revenue
Earnings

ACRX Income statement / Annual

Last year (2024), AcelRx Pharmaceuticals, Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2024, AcelRx Pharmaceuticals, Inc.'s net income was -$13.00 M. See AcelRx Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $651.00 K $1.77 M $2.82 M $5.42 M $2.29 M $2.15 M $8.00 M $17.36 M $19.26 M
Cost of Revenue $0.00 $0.00 $2.59 M $3.75 M $6.03 M $6.81 M $3.98 M $10.66 M $12.32 M $1.77 M
Gross Profit $0.00 $651.00 K -$820.00 K -$935.00 K -$616.00 K -$4.52 M -$1.83 M -$2.66 M $5.04 M $17.49 M
Gross Profit Ratio 0 1 -0.46 -0.33 -0.11 -1.97 -0.85 -0.33 0.29 0.91
Research and Development Expenses $6.72 M $5.55 M $3.34 M $4.10 M $4.02 M $4.66 M $13.14 M $19.41 M $21.40 M $22.49 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $43.93 M $20.77 M $16.61 M $15.60 M $14.20 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $1.10 M $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $8.53 M $11.99 M $25.67 M $30.94 M $36.33 M $45.03 M $20.77 M $14.20 M $15.60 M $14.20 M
Other Expenses $0.00 $0.00 $84.05 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $15.25 M $17.54 M $30.87 M $35.03 M $40.35 M $49.69 M $33.90 M $36.02 M $37.00 M $36.69 M
Cost And Expenses $15.25 M $17.54 M $38.40 M $38.78 M $46.38 M $56.49 M $37.88 M $46.68 M $49.31 M $38.46 M
Interest Income $0.00 $6.74 M $1.50 M $3.16 M $3.89 M $2.17 M $1.14 M $510.00 K $918.00 K $1.72 M
Interest Expense -$394.00 K $134.00 K $1.12 M $2.29 M $3.31 M $1.20 M $12.56 M $14.04 M $12.15 M $5.41 M
Depreciation & Amortization $0.00 $311.00 K $1.65 M $1.97 M $1.85 M $1.67 M $575.00 K $1.74 M $2.05 M $1.98 M
EBITDA -$15.25 M -$9.84 M -$17.20 M -$30.83 M -$35.22 M -$52.04 M -$34.59 M -$36.43 M -$28.99 M -$15.49 M
EBITDA Ratio 0 -15.12 -9.71 -10.94 -6.5 -22.73 -16.08 -4.56 -1.67 -0.8
Operating Income Ratio 0 -25.94 -11.49 -12.76 -7.56 -23.68 -16.61 -4.84 -1.84 -1.04
Total Other Income/Expenses Net $2.25 M $6.60 M $84.40 M $871.00 K $588.00 K $968.00 K -$11.42 M -$13.53 M -$11.23 M -$3.69 M
Income Before Tax -$13.00 M -$10.29 M $59.14 M -$35.09 M -$40.38 M -$53.24 M -$47.15 M -$52.21 M -$43.19 M -$23.64 M
Income Before Tax Ratio 0 -15.8 33.39 -12.45 -7.45 -23.26 -21.92 -6.53 -2.49 -1.23
Income Tax Expense $0.00 $0.00 $13.00 K $5.00 K $4.00 K $3.00 K $2.00 K -$701.00 K -$34.00 K $760.00 K
Net Income -$13.00 M -$10.29 M $47.76 M -$35.10 M -$40.38 M -$53.24 M -$47.15 M -$51.51 M -$43.16 M -$24.40 M
Net Income Ratio 0 -15.8 26.96 -12.46 -7.46 -23.26 -21.92 -6.44 -2.49 -1.27
EPS -0.87 -0.0007 5.73 -5.86 -9.4 -13.4 -16.2 -22 -19.05 -11
EPS Diluted -0.87 -0.0007 5.72 -5.86 -9.4 -13.4 -16.2 -21.97 -19.05 -12
Weighted Average Shares Out $16.16 M $14.26 M $7.39 M $5.99 M $4.26 M $3.96 M $2.92 M $2.34 M $2.27 M $2.22 M
Weighted Average Shares Out Diluted $16.16 M $14.26 M $7.41 M $5.99 M $4.26 M $3.96 M $2.92 M $2.34 M $2.27 M $2.22 M
Link